Data From a Phase I Study of a Drug to Treat Systemic Mastocytosis Has Been Released
jarmoluk / Pixabay

Data From a Phase I Study of a Drug to Treat Systemic Mastocytosis Has Been Released

Promising data from the ongoing Phase I clinical trial Explorer has been announced by Blueprint Medicines Corporation. The trial is designed to evaluate the effects of the experimental drug avapritinib…

Continue Reading Data From a Phase I Study of a Drug to Treat Systemic Mastocytosis Has Been Released
Phase 1 Trial Set to Begin For Experimental Therapy For Multiple System Atrophy and Progressive Supranuclear Palsy
source: pixabay.com

Phase 1 Trial Set to Begin For Experimental Therapy For Multiple System Atrophy and Progressive Supranuclear Palsy

According to a story from businesswire.com, the company Prana Biotechnology Ltd recently announced that it is beginning the recruitment process for its Phase 1 clinical trial of its investigational product…

Continue Reading Phase 1 Trial Set to Begin For Experimental Therapy For Multiple System Atrophy and Progressive Supranuclear Palsy
An Experimental Treatment For PFIC Has Been Awarded Rare Pediatric Disease Designation by the FDA
kreatikar / Pixabay

An Experimental Treatment For PFIC Has Been Awarded Rare Pediatric Disease Designation by the FDA

The U.S. Food and Drug Administration has granted the experimental drug A4250 rare paediatric disease designation for the treatment of progressive familial intrahepatic cholestasis. The full article can be found…

Continue Reading An Experimental Treatment For PFIC Has Been Awarded Rare Pediatric Disease Designation by the FDA

Investigational Drug For Limbal Stem Cell Deficiency Gets Orphan Drug Designation

According to a story from pm360online.com, the speciality pharmaceutical company Chiesi USA and the biotech company Holostem Terapie Avanzate S.r.l. of Italy recently announced that the U.S. FDA recently granted orphan…

Continue Reading Investigational Drug For Limbal Stem Cell Deficiency Gets Orphan Drug Designation
Medical Research Network is Improving Clinical Trials
https://pixabay.com/en/hospital-ward-hospital-medical-room-1338585/

Medical Research Network is Improving Clinical Trials

Medical Research Network (MRN) is an organisation that specialises in the conduct of clinical trial visits in the patient’s home and supporting clinical trial sites with nursing resources. MRN aims…

Continue Reading Medical Research Network is Improving Clinical Trials
This Over-The-Counter Medicine Could Help Fend Off Cancer in People with Barrett’s Esophagus
Source: Pixabay

This Over-The-Counter Medicine Could Help Fend Off Cancer in People with Barrett’s Esophagus

According to Wilts and Gloucestershire Standard, aspirin is potentially the difference maker in preventing esophageal cancer, especially among those at high risk for the cancer. Esophageal cancer originates in the…

Continue Reading This Over-The-Counter Medicine Could Help Fend Off Cancer in People with Barrett’s Esophagus
A Study of an Investigational Drug For Primary Hyperoxaluria Has Dosed its First Patient
Source: Pixabay

A Study of an Investigational Drug For Primary Hyperoxaluria Has Dosed its First Patient

Dicerna Pharmaceuticals has dosed the first patient with primary hyperoxaluria in Group B of a clinical trial of the investigational drug DCR-PHXC. Dicerna has also announced that DCR-PHXC has just…

Continue Reading A Study of an Investigational Drug For Primary Hyperoxaluria Has Dosed its First Patient